Suppr超能文献

相似文献

1
Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure.
Circ Res. 2025 Jul 7;137(2):290-315. doi: 10.1161/CIRCRESAHA.125.325534. Epub 2025 Jul 3.
2
Contribution of reduced skeletal muscle perfusion reserve to exercise intolerance in heart failure with preserved ejection fraction.
Int J Cardiol. 2024 Jan 15;395:131553. doi: 10.1016/j.ijcard.2023.131553. Epub 2023 Oct 21.
3
Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and All-Cause Mortality in Patients With Chronic Heart Failure.
Circ Heart Fail. 2025 Jun;18(6):e012754. doi: 10.1161/CIRCHEARTFAILURE.124.012754. Epub 2025 Apr 14.
6
Interventions for promoting habitual exercise in people living with and beyond cancer.
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
7
Coenzyme Q10 for heart failure.
Cochrane Database Syst Rev. 2021 Feb 3;(2)(2):CD008684. doi: 10.1002/14651858.CD008684.pub3.
9
Determinants of exercise intolerance in heart failure with preserved ejection fraction: A systematic review and meta-analysis.
Int J Cardiol. 2018 Mar 1;254:224-229. doi: 10.1016/j.ijcard.2017.10.114. Epub 2018 Jan 28.

本文引用的文献

2
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
JAMA Cardiol. 2025 Mar 1;10(3):284-289. doi: 10.1001/jamacardio.2024.4417.
3
4
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med. 2025 Jan 30;392(5):427-437. doi: 10.1056/NEJMoa2410027. Epub 2024 Nov 16.
6
Cardiopulmonary Exercise Testing in Advanced Heart Failure Management.
Heart Fail Clin. 2025 Jan;21(1):35-49. doi: 10.1016/j.hfc.2024.09.001. Epub 2024 Oct 18.
8
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial.
Circulation. 2024 Dec 10;150(24):1931-1943. doi: 10.1161/CIRCULATIONAHA.124.070870. Epub 2024 Sep 23.
9
Pulmonary hypertension associated with left heart disease.
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01344-2024. Print 2024 Oct.
10
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors.
JACC Heart Fail. 2024 Nov;12(11):1814-1826. doi: 10.1016/j.jchf.2024.07.006. Epub 2024 Aug 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验